Luveltamab tazevibulin
STRO-002-GM3
Phase 3 small_molecule terminated
Quick answer
Luveltamab tazevibulin for Ovarian Cancer is a Phase 3 program (small_molecule) at SUTRO BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUTRO BIOPHARMA, INC.
- Indication
- Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated